Company news

Illumina, Inc. news in 2020

Illumina, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

December 7, 2020

Illumina to Webcast Upcoming Investor Conference Presentation

November 17, 2020

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020

October 28, 2020

Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020

September 27, 2020

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

September 20, 2020

Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System

September 13, 2020

Illumina Welcomes Kathryne Reeves as Chief Marketing Officer

August 24, 2020

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020

August 5, 2020

Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome

August 5, 2020

Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020

July 15, 2020

Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

July 7, 2020

Illumina Accelerator Welcomes First Global Cohort of Genomics Startups

June 22, 2020

Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale

June 16, 2020

Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies

June 15, 2020

Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

June 8, 2020

Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research

May 17, 2020

Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development

May 3, 2020

Illumina Reports Financial Results for First Quarter of Fiscal Year 2020

April 29, 2020

Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance

April 27, 2020

Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19

April 15, 2020

Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020

April 13, 2020

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

February 26, 2020

Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors

February 5, 2020

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019

January 28, 2020

Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020

January 12, 2020

Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics

January 12, 2020

Illumina and Roche Partner to Broaden Patient Access to Genomic Testing

January 12, 2020

ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests

January 9, 2020

Illumina and Pacific Biosciences Announce Termination of Merger Agreement

January 1, 2020

Decks in 2020